1274952

Novo Nordisk Pharmaceutical Industries LP — FEI 3016799712

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 30, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Durham, NC (United States)